Tool to track progression: Dr. Nicholas LaRocca of the National MS Society described efforts of the newly-formed MS Outcome Assessments Consortium (MSOAC) to accelerate development of more effective treatments for multiple sclerosis, particularly for progressive forms of MS. MSOAC is a coalition of industry, academia, patient representatives, regulatory and other government agencies, and the Natio